Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
CSW CEO Joseph B. Armes Sells 1,500 Shares
What Happened
- Joseph B. Armes, Chairman, President & CEO (and Director) of CSW Industrials (CSW), sold 1,500 shares on February 17, 2026.
- The weighted-average sale price was $297.79 per share (sales ranged from $297.20 to $299.32), for total proceeds of approximately $446,685. The sales were effected pursuant to a 10b5-1 trading plan established August 12, 2025.
Key Details
- Transaction date: 2026-02-17. Report filed: 2026-02-18 (timely).
- Price: weighted average $297.79; individual sale prices ranged $297.20–$299.32. Full breakdown available upon request per the filer.
- Shares sold: 1,500; proceeds ≈ $446,685.
- Shares owned after transaction: not disclosed in the provided excerpt of the filing.
- Notable footnotes: sale executed under a 10b5-1 plan (pre-arranged trading plan). Filing also includes multiple footnotes describing outstanding performance rights and restricted stock units, but those are grant/award descriptions and not part of this sale.
Context
- This was an open-market sale under a pre-set 10b5-1 plan, which typically indicates the trades were scheduled in advance and not an opportunistic, real-time signal from the insider. Sales are generally less informative than purchases for gauging insider confidence, and the presence of a 10b5-1 plan further suggests routine disposition.
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-17$297.79/sh−1,500$446,685→ 61,026 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 8,004
Performance Rights
[F3]→ Common Stock (8,004 underlying) - 8,236
Performance Rights
[F4]→ Common Stock (8,236 underlying) - 12,422
Performance Rights
[F5]→ Common Stock (12,422 underlying) - 18,372
Performance Rights
[F6]→ Common Stock (18,372 underlying) - 19,685
Restricted Stock Units
[F7]→ Common Stock (19,685 underlying)
Footnotes (7)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.20 to $299.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles ending on each of March 31, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F7]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Signature
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes|2026-02-18